Lexi Ventures
Venture capitalActively deployingSan Francisco · Seed · 2 people tracked
Find your way into Lexi Ventures
1,364 people in our graph share verified history with the Lexi Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The firm believes biology has transitioned from a science to an engineering discipline, enabling precise reading, writing, and editing of life's genetic code at unprecedented scale. Gene technology startups can address many severe and costly diseases, improve quality of life, and reduce healthcare burdens. Additionally, gene tech enables sustainable production of new materials and products through engineered plants and microbes. Lexi targets companies leveraging DNA, RNA, cellular engineering, and omics technologies to create these solutions.
Source: firm website, verified Aug 11, 2026.
Team · 2 people
from public directories
What they invest in
from 5 of 11 portfolio companiesBiotech ×5Deep Tech ×3AI & Machine Learning ×2Healthtech ×2Medical Devices ×2Advanced Manufacturing ×1Cleantech ×1Consumer ×1
HQs:United States×3
Investments · 11 tracked
founders shown can be your intro path
AlkaLi Labs develops microbial hyperaccumulators that extract critical minerals, including lithium, from industrial waste streams to supply materials needed for green energy hardware and electrification.
BiotechCleantechNew Materials
Co-investorsCyclotron Road
RNA-based antisense therapeutics for rare genetic diseases.
Developing next-generation protein sequencing platform to redefine proteomics.
Co-investorsModi Ventures
High-fidelity CRISPR tools designed for safer, rapid clinical translation.
Engineering T-cells to eradicate solid tumors without viral vectors.
Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Mridu Sinha, PhD(Co-Founder and CEO)Stephanie Fraley, PhD(Co-Founder)
ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
David Weinberg(Founder)inChris Carlson(Founder)in
BoardMorgan Cheatham(Director)in
Co-investorsY CombinatorBreyer CapitalGeneral CatalystMetaplanetNorth South VenturesRitual Capital+3 more
QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.
BiotechDeep TechMedical Devices
Charles Blanluet(Founder)in
Co-investorsCivilization Ventures Management, LlcHCVC
AI simulation platform predicting clinical trial outcomes and metabolic pathways.
Taxa develops probiotic skincare products that target the skin microbiome, including a single-application deodorant cream that lasts one week.
Advanced ManufacturingBiotechConsumerWellness & FitnessHouston, US
Garrett Finney(Executive Officer, Director)Amitav Misra(Executive Officer, Director)Xavier M. Segel(Founder)inJ. Antonio Gonzalez(Executive Officer, Director)
BoardMichael Bland(Director)Russell Radoff(Director)
Co-investorsBlack Jays VenturesMidnightSpacecadet VenturesMatrix
Precision genetic medicines targeting rare and neglected pediatric diseases.
Portfolio news
latest coverage across their companiesParcelBio · technews180.com · May 8, 2026
Frequently asked questions
- How many investments has Lexi Ventures made?
- Lexi Ventures has 11 tracked investments, including 1 dated in the last 24 months.
- What stage does Lexi Ventures invest at?
- Lexi Ventures invests at the Seed stage.
- What sectors does Lexi Ventures focus on?
- Lexi Ventures focuses on AgTech, Biotech, Deep Tech, Healthtech.
- Where is Lexi Ventures located?
- Lexi Ventures is headquartered in San Francisco, US.
- Who does Lexi Ventures co-invest with?
- Lexi Ventures most often shares deals with Spacecadet Ventures, Civilization Ventures Management, Llc, HCVC, among 13 tracked co-investors.
Co-investors · 1
Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.
Firms observed investing alongside Lexi Ventures, from public investor directories. Shared companies are the overlap with Lexi Ventures's recorded portfolio.
Similar investors
Granatus Ventures is a venture capital firm that backs startups worldwide leveraging Armenia's potential as an emerging technology hub.
Taiwania Capital is a venture capital firm investing across technology and life science sectors, backing companies in Taiwan, Europe, and globally.
Redalpine is a multi-stage venture investment advisor with Swiss roots and a pan-European focus, active since 2006, that invests at the intersection of software and science.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Asia2G (A2G) Capital is a Silicon Valley venture capital firm that invests primarily in early-stage Korean and Asian technology startups seeking to expand globally.